ORIGIO A/S
Stamdata
Navn | ORIGIO A/S |
Adresse | Lautrupvang 2 1 th, 2750, Ballerup |
Stiftelsesdato | 1. jul. 1987 |
Antal | 83 / 82 |
Lokationer (P-enheder) | 1Se lokationer |
Hjemmeside | https://www.coopersurgical.com/brand/origio/ |
Branche | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Navn | ORIGIO A/S |
Adresse | Lautrupvang 2 1 th, 2750, Ballerup |
Stiftelsesdato | 1. jul. 1987 |
Antal | 83 / 82 |
Lokationer (P-enheder) | 1Se lokationer |
Hjemmeside | https://www.coopersurgical.com/brand/origio/ |
Branche | Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000) |
Hold øje med ORIGIO A/S
Beskrivelse
ORIGIO has been part of the CooperSurgical Companies since 2012. CooperSurgical Fertility Solutions is the global leader in IVF (In Vitro Fertilisering) and reproductive genetics, providing innovative products and services for every step in the ART journey (Assisted Reproductive Technology). Our company vision is a world with healthy women, babies and families. ORIGIO A/S was established in 1987 and has been a global leader in delivering innovative ART solutions. Combining the scientific knowledge with the CooperSurgical fertility companies ORIGIO, Research Instrument, Safe Obstetrics Systems and Invitro offer a broad range of trusted systems of consumables, equipment, and technologies for a complete IVF process. In 2016 Reprogenetics, Recombine and Genesis Genetics joined the CooperSurgical family, and represented the pioneers and global leaders of comprehensive reproductive genetic testing. As CooperGenomicsSM, they are the premier provider of genetic testing for every step of the family planning journey. Our combined product range includes pipettes, media and andrology products, and dedicated ART equipment, as well as state-of-the art electronic witnessing system. Our broad portfolio of products and services are being developed jointly in partnerships with experts and clinics across the globe to improve the ART solutions. Our industry-leading ART development program includes 7 Centers of Excellence around the world as well as collaboration with our external partners' training facilities, such as the Centre of Reproductive Medicine at the Vrije Universiteit Brussel in Brussels. We offer a wide range of courses and workshops for embryologists, gynecologists, lab managers and R&D scientists at every level of experience, with hands-on expert training in breakthrough technologies and next-generation techniques. Our team of experienced embryologists also assists customers with the establishment of clinics (tum-key projects), laboratory design, and clinic audits to optimize lab performance. In addition, they give lectures, run seminars and workshops, and support the research and development of new products. ORIGIO will continue its focus to further grow and strengthening it's strong position in offering best in class products, driving and evolving innovation in line with customer needs. The collaboration within the CooperSurgical Companies and trusted partnerships open doors to extensive possibilities for the future.
Økonomi
| Regnskabsperiode | 2024/251. nov. 2024 - 31. okt. 2025kr. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Omsætning | 760.810.000 | ||||||||
| Bruttofortjeneste | 157.449.000 | ||||||||
| Driftsresultat | 32.868.000 | ||||||||
| Resultat før skat | 9.305.000 | ||||||||
| Årets resultat | 4.884.000 | ||||||||
| Samlede aktiver | 443.349.000 | ||||||||
| Egenkapital | 171.727.000 | ||||||||
| Gns. ansatte | 107 | ||||||||
2017–2025 Lås regnskabshistorikken op | |||||||||
Datapublica Risk Score
Det indgår i vurderingen
Økonomi
Soliditet, indtjening og likviditet
Regnskaber og historik
Sene regnskaber og tidligere økonomiske problemer
Ejere og ledelse
Tidligere konkurser og ejernes øvrige virksomheder
Virksomhed og relationer
Alder, branche og delte adresser eller kontaktoplysninger
Standard: Score og risikoniveauPro: Også detaljeret forklaring af faktorerne
Gazelle
Henter gazelle-status…
Børsen Gazelle er Dagbladet Børsens kåring. Datapublica er ikke tilknyttet Børsen. Beregnede statusser er Datapublicas egen analyse af offentlige CVR-regnskabsdata.
Ledelse og roller
Ingen aktuelle ledelses- eller rolleoplysninger tilgængelige
Revisor
| Revisionsfirma | Revisor | Rolle | Fra |
|---|---|---|---|
| KPMGStatsautoriseret Revisionspartnerselskab | RevisorIlhan Dogan | RolleState Authorised Public Accountant | Fra18. maj 2026 |
Legale ejere
| Ejer | Ejerandel | Stemmeandel | Fra |
|---|---|---|---|
Udenlandsk juridisk enhed | Ejerandel100 % | Stemmeandel100 % | Fra29. jan. 2016 |
Dattervirksomheder
| Virksomhed | Ejerandel | Stemmeandel | Fra |
|---|---|---|---|
| Ejerandel100 % | Stemmeandel100 % | Fra17. aug. 1994 |
Ultimative ejere
| Navn | Ejerskab gennem | Beregnet ejerandel |
|---|---|---|
| 🇬🇧RESEARCH INSTRUMENTS LIMITED | Ejerskab gennem Direkte | 100 % |